Glenmark Pharmaceuticals

Glenmark Pharmaceuticals

GLENMARK

 ₹ 1,014.30
- ₹ 13.30
-1.29%

Glenmark Pharmaceuticals  
Market Sentiment

TimelineReturnsVolume
Daily-1.29%3,09,747
Weekly-0.51%13,82,661
Monthly-5.29%1,05,32,387

Glenmark Pharmaceuticals  
Performance

TimelineDailyWeeklyMonthly
GLENMARK-1.29%-0.51%-5.29%
Index-3.57%-1.42%-1.14%
Peer Avg.-0.08%0.79%2.23%
*Avg of index constituents

Glenmark Pharmaceuticals  
Fundamentals

TimelinePEPBEV/EBIDTAROEROCEDiv. Yield
GLENMARK9.751.065.5812.5013.720.59
Index36.206.7717.2517.8919.691.20
Peer Avg.39.554.7512.3513.5917.020.87
*Avg of index constituents

Glenmark Pharmaceuticals  
Key Metrics

MetricsSales GrowthProfit GrowthROEROCE
FY '21-2210.01%11.77%12.5013.72
FY '20-217.79%23.39%13.2913.92
FY '19-201.82%-16.30%12.0512.64

Glenmark Pharmaceuticals  
Shareholding Pattern

PromotersFIIDIIPublicOthers
Promoters : 46.65%
FII : 24.12%
DII : 10.96%
Public : 18.27%
Others : 0%

Glenmark Pharmaceuticals  
Profit & Loss

MetricsSalesExpenditureEBITDAPAT
FY '21-2210,223.248,218.982,394.911,495.72
FY '20-219,255.937,268.572,210.591,309.77
FY '19-208,676.807,175.641,884.351,065.26
All values are in crores

Glenmark Pharmaceuticals  
Peer Comparison

MetricsSalesExpenditureEBITDAPAT
GLENMARK10,223.248,218.982,394.911,495.72
CAMPUS1,194.18952.43244.15108.15
BLUESTARCO5,711.285,417.27354.92147.32
All values are in crores

Glenmark Pharmaceuticals  
Similar Stocks

Cipla

Cipla

CIPLA

 ₹ 1,485.20
- ₹ 3.95
-0.26%
Dr. Reddy's Laboratories
 ₹ 5,875.60
- ₹ 22.10
-0.37%
Lupin

Lupin

LUPIN

 ₹ 1,627.45
- ₹ 5.20
-0.31%
Torrent Pharmaceuticals
 ₹ 2,658.30
- ₹ 34.60
-1.28%
Glaxosmithkline Pharmaceuticals
 ₹ 2,473.90
 ₹ 0.35
0.01%

Glenmark Pharmaceuticals Share Price

Glenmark Pharmaceuticals Ltd has a significant presence in the branded generics market in all emerging economies including India. The company entered the dermatology market with the launch of Candid cream. Glenmark's pioneering drug development focuses primarily on inflammation [asthma/COPD, rheumatoid arthritis, etc.], metabolic disorders [diabetes, obesity, etc.] and pain [neuropathic pain and inflammatory pain]. The company's formulation business focuses on therapeutic areas, e.g. dermatology, infectious medicine, respiratory, cardiac, diabetes, gynecology, central nervous system and oncology. India is the organization's largest market region by revenue.

Glenmark Pharmaceuticals FAQs

How to Buy Glenmark Pharmaceuticals Share?

virtual
To purchase Glenmark Pharmaceuticals shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Glenmark Pharmaceuticals (ticker symbol: glenmark) on the trading platform provided by your broker and purchase the shares.

What's Glenmark Pharmaceuticals share price today?

virtual
The stock price of Glenmark Pharmaceuticals as of 24 May 2024 is ₹1,014.30

What is the Market Cap of Glenmark Pharmaceuticals?

virtual
Market capitalisation represents the total market value of a company's outstanding shares. As of 24 May 2024, Glenmark Pharmaceuticals (ticker symbol: glenmark) has a market capitalisation of approximately ₹1,18,60,93,84,374.60

What is the PE and PB ratio of Glenmark Pharmaceuticals?

virtual
Glenmark Pharmaceuticals Ltd's price-to-book ratio as of 24 May 2024 is 1.0605962, reflecting the market's valuation compared to its asset value. As of 24 May 2024, the trailing twelve months P/E (price-to-earnings) ratio is 9.748197, indicating the market values the company at around ₹9.75 for every ₹1 of earnings

What is the 52 Week High and Low of Glenmark Pharmaceuticals Share?

virtual
Glenmark Pharmaceuticals Ltd (glenmark) hit its 52-week high at ₹1,098.00, and its 52-week low at { ₹587.00}.
Want to learn and earn in Stocks?